We are live on ! Find out more
AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

58 hedge funds and large institutions have $79M invested in AVEO Pharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

408% more call options, than puts

Call options by funds: $3.34M | Put options by funds: $657K

9% more capital invested

Capital invested by funds: $72.3M → $79M (+$6.65M)

0% more funds holding

Funds holding: 58 → 58 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

13% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 15

Holders
58
Holders Change
–
Holders Change %
0%
% of All Funds
0.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
13
Reduced
15
Closed
9
Calls
$3.34M
Puts
$657K
Net Calls
+$2.68M
Net Calls Change
+$1.32M

Top Buyers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
+$1.09M
2
SSA
Schonfeld Strategic Advisors
New York
+$956K
3
Millennium Management
Millennium Management
New York
+$637K
4
WVP
Worth Venture Partners
New Jersey
+$494K
5
JGC
J. Goldman & Co
New York
+$368K

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$7.04M
2
Goldman Sachs
Goldman Sachs
New York
-$1M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$878K
4
PVI
Pura Vida Investments
New York
-$579K
5
Citadel Advisors
Citadel Advisors
Florida
-$463K
Name Holding Trade Value Shares
Change 		Change in
Stake
LFG
51
Larson Financial Group
Missouri
$3K – – –
WIM
52
Westside Investment Management
California
$2.77K – – –
TFGT
53
TS Financial Group (TSFG)
Illinois
$2K – – –
AF
54
Advisornet Financial
Minnesota
$1K – – –
JP Morgan Chase
55
JP Morgan Chase
New York
$1K – – –
National Bank of Canada
56
National Bank of Canada
Quebec, Canada
$1K – – –
Adage Capital Partners
57
Adage Capital Partners
Massachusetts
– -$7.04M -1,500,000 Closed
PVI
58
Pura Vida Investments
New York
– -$579K -123,416 Closed
Citadel Advisors
59
Citadel Advisors
Florida
– -$463K -112,347 Closed
SCP
60
Sender Company & Partners
New York
– -$432K -92,026 Closed
JF
61
Jump Financial
Illinois
– -$113K -24,181 Closed
XT
62
XTX Topco
Cayman Islands
– -$85K -18,128 Closed
SC
63
Shay Capital
New York
– -$62K -13,243 Closed
EWM
64
Edge Wealth Management
New York
– -$5K -1,000 Closed
BBPWM
65
Blue Bell Private Wealth Management
Pennsylvania
– +$82 +20 New
1 2
3

AVEO Hedge Fund Activity: Q1 2022 in Review

58 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q1 2022, worth a combined $79M — up 9.2% from $72.3M a quarter earlier.

Fund positioning in AVEO was balanced in Q1 2022: 9 funds opened new positions, 9 closed out, 13 added to existing stakes and 15 trimmed.

The largest buyer was AIGH Capital Management, adding an estimated $1.09M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $7.04M sold.

  • 58 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $79M of AVEO Pharmaceuticals, Inc. stock for Q1 2022, up 9.2% quarter-over-quarter.
  • 9 funds opened new AVEO Pharmaceuticals, Inc. positions in Q1 2022 and 9 closed out, a net change of 0 holders.
  • The largest AVEO Pharmaceuticals, Inc. buyer in Q1 2022 was AIGH Capital Management, an estimated $1.09M added.
  • The largest AVEO Pharmaceuticals, Inc. seller in Q1 2022 was Adage Capital Partners, an estimated $7.04M sold.

Based on aggregated 13F filings for Q1 2022.